Multi-Agent Based Automation of Genomic Variant Report Interpretation Support

This workflow automates the critical research bottleneck in precision oncology, where clinicians manually correlate identified variants with literature, clinical trials, and pathogenicity databases—a process consuming 2-4 hours per complex case. The business value is direct labor leverage, accelerating treatment planning and improving trial matching throughput. Implementation requires building a retrieval-augmented generation (RAG) system over curated sources like ClinVar, COSMIC, and PubMed, with agents specialized for literature synthesis, trial matching, and clinical context retrieval, all orchestrated within a framework like LangGraph.

The solution integrates directly with Laboratory Information Systems (LIS) like Epic Beaker or Sunquest. Orchestration logic manages API calls, handles data quality exceptions, and routes low-confidence summaries for human review via a dedicated genetic counselor dashboard. Controls include audit trails for all evidence citations, configurable confidence thresholds, and mandatory cosignature workflows for high-impact findings. The final architecture reduces variant interpretation cycle time by over 70%, creating a scalable, auditable support layer for molecular tumor boards.

This workflow automates the manual, hours-long research process required to interpret a genomic variant report. Upon receiving a finalized lab report, an orchestrator triggers specialized agents to retrieve relevant literature, clinical trial matches, and pathogenicity predictions from curated databases like ClinVar and COSMIC. The business value is direct: it reduces the time for a genetic counselor or oncologist to assess a variant's clinical significance from hours to minutes, accelerating treatment decisions and improving patient throughput in precision medicine programs.

Implementation requires building a RAG pipeline over licensed genomic knowledge bases, with agents fine-tuned for specific retrieval tasks. The orchestrator, built on a framework like LangGraph, manages context, handles agent errors, and enforces approval gates. The final interpreted summary, complete with citations and confidence scores, is routed via the EHR's in-basket for oncologist review and sign-off before integration into the patient's clinical record. Key controls include audit trails for all agent decisions, configurable confidence thresholds for auto-routing, and seamless integration with existing LIS and EHR systems like Epic or Cerner to avoid disruptive workflow changes.

This workflow automates the manual research bottleneck in precision oncology, where genetic counselors and oncologists spend hours per case retrieving literature, clinical trials, and pathogenicity data for identified variants. The operational upside comes from reducing interpretation time from hours to minutes, standardizing evidence review, and accelerating therapy matching. Implementation begins with a pilot on a single cancer type, integrating with the Laboratory Information System (LIS) via HL7 to ingest structured variant call format (VCF) reports and patient context from the EHR.

Phase two focuses on validation, running a controlled pilot for a specific cancer (e.g., NSCLC) with defined oversight from molecular tumor boards. Agents built on LangGraph orchestrate retrieval from curated sources like ClinVar and CIViC, generating draft summaries with citations. The final scale phase adds multi-cancer logic, embeds the workflow into standard operating procedures, and deploys a clinician-facing overlay within the EHR or a dedicated portal, complete with confidence scoring, approval gates, and a full audit trail for compliance.

This workflow automates the manual, hours-long research required per case to interpret genomic variant reports, directly improving precision medicine throughput. It retrieves and synthesizes evidence from curated databases like ClinVar, COSMIC, and clinical trial registries, presenting oncologists with a consolidated, evidence-backed summary. The operational upside comes from reducing diagnostic latency, standardizing interpretation quality, and freeing specialist time for higher-value patient consultation, directly impacting treatment initiation speed and trial enrollment efficiency.

Implementation requires building a RAG system over genomic knowledge bases and designing a secure orchestration layer, typically using LangGraph or a custom microservices architecture. Agents must integrate with the Laboratory Information System (LIS) via HL7 or FHIR APIs to ingest variant call format (VCF) files. Critical controls include mandatory genetic counselor review for low-confidence or novel variants, immutable audit trails for all evidence citations, and phased clinical rollout starting with a pilot cohort. Monitoring focuses on agent accuracy, processing latency, and clinician acceptance metrics.

This workflow automates the manual research bottleneck in precision oncology, where clinicians spend hours per case cross-referencing variant reports against fragmented databases like ClinVar, COSMIC, and PubMed. The operational upside is a 70-90% reduction in literature review time per variant, accelerating treatment decisions and improving clinic throughput. Implementation requires building a secure RAG system over curated genomic knowledge bases and designing an agentic orchestration layer that integrates with Laboratory Information Systems (LIS) like Epic Beaker or Sunquest.

The architecture must enforce strict data governance, with all agent outputs routed through a human-in-the-loop review queue before final sign-off into the patient record. Implementation involves deploying the orchestration layer (e.g., LangGraph) within the health system's HIPAA-compliant cloud, integrating via FHIR APIs and HL7v2 feeds for real-time LIS ingestion. Critical controls include audit trails for all data retrievals, configurable confidence thresholds for auto-routing, and exception handling for ambiguous or conflicting evidence that escalates to a molecular tumor board.